News Quantified

RGEN – repligen corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Repligen (RGEN) is now covered by Roth Mkm. They set a "buy" rating and a $160.00 price target on the stock.

Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network

Repligen (RGEN) was given a new $160.00 price target by Rothschild & Co Redburn.

Repligen (RGEN) had its "overweight" rating reaffirmed by Barclays PLC.

1 Cash-Producing Stock Worth Your Attention and 2 We Avoid [Yahoo! Finance]

0.2%

BEAT

-7.0%

BEAT

5.9%

MISS

-7.8%

BEAT

Form ARS REPLIGEN CORP For: Dec 31

Form DEFA14A REPLIGEN CORP

Form DEF 14A REPLIGEN CORP For: May 14

Form SCHEDULE 13G/A REPLIGEN CORP Filed by: VANGUARD GROUP INC

Form 4 REPLIGEN CORP For: Mar 05 Filed by: KURIYEL RALF

Top News Gainers

3/3 Edwards Lifesciences Shows Improved Price Strength & IBD Rating Upgrade [Investor's Business Daily] 8.7%

7/15 Form 8-K REPLIGEN CORP For: Jul 15 7.9%

10/31 Repligen Exits Third Quarter Armed With a $500 Million War Chest [The Motley Fool] 6.6%

4/22 Repligen to Report First Quarter 2020 Financial Results 5.4%

3/10 Repligen Co. (NASDAQ: RGEN) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 4.8%

6/4 Repligen to Present at Jefferies 2019 Healthcare Conference 4.8%

4/28 Form DEF 14A REPLIGEN CORP For: May 13 4.6%

11/14 Repligen Co. (NASDAQ: RGEN) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating on the stock. 3.4%

5/9 Q1/2019 3/31/2019 EPS 0.280 ZacksConsensus 0.260 ActVsEst 0.020 - Beat 3.4%

5/15 Form 4 REPLIGEN CORP For: May 13 Filed by: Snodgres Jon 3.3%

Top News Decliners

3/13 IBD Watchlists See Frothy Tide Of Incoming Stocks Amid Coronavirus Correction [Investor's Business Daily] -11.7%

3/23 Repligen Co. (NASDAQ: RGEN) had its price target lowered by analysts at HC Wainwright from $110.00 to $100.00. They now have a "buy" rating on the stock. -10.2%

3/18 Form 4 REPLIGEN CORP For: Mar 16 Filed by: RYAN THOMAS F JR -9.8%

2/20 Repligen Reports Fourth Quarter and Full Year 2019 Financial Results -8.1%

2/24 Form 4 REPLIGEN CORP For: Feb 21 Filed by: DAWES KAREN A -7.7%

8/1 Form 10-Q REPLIGEN CORP For: Jun 30 -6.7%

8/2 Repligen Corporation (RGEN) CEO Tony Hunt on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -5.7%

8/1 Q2/2019 6/30/2019 EPS 0.310 ZacksConsensus 0.250 ActVsEst 0.060 - Beat -4.3%

4/6 Form 4 REPLIGEN CORP For: Apr 03 Filed by: BARTHELEMY NICOLAS -3.5%

2/6 Repligen to Report Fourth Quarter and Full Year 2019 Financial Results -3.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day